Clin2
NCT06952140Worth exploringNot yet recruiting

Ketone Esters for Sepsis-Related Heart Weakness

Sepsis Induced Cardiomyopathy

Part of Hormones & metabolism, Infections clinical trials.

This trial tests whether a drink containing ketone esters can help improve heart function in patients with sepsis-related heart muscle weakness. You may be eligible if you are in the ICU with an infection and have a weakened heart pump.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
12 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You are currently in the intensive care unit (ICU)
  • You have a suspected or confirmed infection (like being on antibiotics or having a culture taken recently)
  • Your heart's pumping ability is less than 50% on a recent ultrasound
  • You did not have heart failure with reduced pumping ability before coming to the ICU
  • Your ICU admission was not due to surgery

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07434466Not yet recruiting
Ketone drink for acute heart failure recovery

This trial tests a special ketone drink to see if it can help people recently hospitalized with acute heart failure feel better and recover faster. It measures how the drink affects the heart and body during the early days in the hospital.

Edmonton, Alberta
NCT06195982Enrolling by invitation· Phase 2
Ketone supplement for heart failure with reduced pumping ability

This trial tests whether a ketone supplement can improve heart function and exercise ability in people with heart failure and a reduced ejection fraction. It may help you feel better during daily activities.

Durham, North Carolina
NCT07017517Recruiting
Exercise therapy for weakness after sepsis in the ICU

This trial tests whether adding physical therapy early in the ICU can help people with sepsis regain strength and reduce muscle weakness. It focuses on patients who need a breathing tube for at least a week and have a high level of organ failure.

Santiago, Metropolitan Region
NCT07364162Recruiting· Phase 2
Ketone drink for confusion in intensive care patients

This trial tests whether giving a special ketone drink to patients in the ICU can reduce or treat delirium (confusion). If you or a loved one is in the ICU, this treatment might help clear up confusion faster.

Nashville, Tennessee
NCT06937320Enrolling by invitation· Phase 2
Testing ketone supplements for heart failure with preserved ejection fraction (HFpEF)

This study tests whether a special dietary supplement (ketone esters) can improve exercise ability and heart function in people with a type of heart failure where the heart pumps well but is stiff (HFpEF). You might join if you have stable symptoms, an ejection fraction of 50% or higher, and signs of fluid buildup in the heart.

Durham, North Carolina
NCT07022041Recruiting
Sepsis and survival in heart patients

This study looks at how sepsis and other infections affect survival in hospitalized heart patients. It is designed for people who are being treated for a heart condition and either have no infection or have a specific type of infection or heart inflammation.

Cosenza

Hear when a new Sepsis Induced Cardiomyopathy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.